Unified eClinical Curebase offers a single unified AI-native eClinical platform that integrates recruitment, compliance, data capture, ePRO, eConsent, EDC, and participant engagement, presenting a comprehensive sales opportunity to sponsors seeking end-to-end trial management with modern technology.

Sites first pricing With Sitebase providing free CTMS, eISF, and eSource to sites, there is a strong value proposition to persuade CROs and sponsors to adopt Curebase by reducing site technology costs and accelerating trial enrollment through enhanced site satisfaction.

Decentralized trials Curebase has a track record and strategic focus on decentralized and home-based trials, including at-home vaccine studies, suggesting cross-sell potential to sponsors prioritizing patient-centric, remote trial designs and broader patient access.

Enterprise readiness Recent leadership hires in engineering and clinical operations, plus HIPAA-compliant integrations with partners like Redenlab, indicate a scalable, enterprise-grade platform suitable for large sponsors seeking robust data quality, security, and interoperability.

Growth and partnerships Funding momentum, notable partnerships with Walgreens and BEKHealth, and a revenue range in the mid-market tier position Curebase to pursue further collaborations with mid-to-large sponsors and health systems seeking modern, patient-friendly trial tech.